Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5219-5238
Author(s):
Paola Dongiovanni, Quentin M. Anstee and Luca Valenti
Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
13
Page:
1025-1031
Author(s):
Ansgar Bruning
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5239-5249
Author(s):
Samuele De Minicis, Chris Day and Gianluca Svegliati-Baroni
Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5280-5296
Author(s):
Lucia Carulli, Mauro Maurantonio, Lionel Hebbard, Enrica Baldelli, Paola Loria and Jacob George
Suppression of Oncoprotein Her-2 and DNA Damage after Treatment with Flavan-3- ol Vitis labrusca Extract
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
13
Page:
1088-1095
Author(s):
Gustavo Scola, Claudia Cilene Fernandes Correia Laurino, Eveline Menin and Mirian Salvador
Targeting Metabolic Enzymes in Cancer – Clinical Trials Update
Journal:
Current Enzyme Inhibition
Volume:
9
Page:
152-160
Author(s):
Julie O’Neal and Jason Chesney
Folic Acid Conjugated Chitosan Nanoparticles for Tumor Targeting of Therapeutic and Imaging Agents
Journal:
Pharmaceutical Nanotechnology
Volume:
1
Page:
184-203
Author(s):
Driton Vllasaliu, Luca Casettari, Giulia Bonacucina, Marco Cespi, Giovanni Filippo Palmieri and Lisbeth Illum
Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5344-5361
Author(s):
Maria Cristina Manara, Cecilia Garofalo, Stefano Ferrari, Antonino Belfiore and Katia Scotlandi
Prospects of miRNA-Based Therapy for Pancreatic Cancer
Journal:
Current Drug Targets
Volume:
14
Page:
1101-1109
Author(s):
Priya Pai, Satyanarayana Rachagani, Chandrakanth Are and Surinder K. Batra
Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine
Journal:
Current Drug Metabolism
Volume:
14
Page:
547-564
Author(s):
Jana Drbohlavova, Jana Chomoucka, Vojtech Adam, Marketa Ryvolova, Tomas Eckschlager, Jaromir Hubalek and Rene Kizek